http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114209668-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_301c1ea82c4a69bb92a51fcefefa0f2e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
filingDate 2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f90444374ead947b7ecd827a77154c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d07bb624fb1cacc51598004096aa446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f016ac1c83cb23eae4f13d6ffe70b416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c779a62fd6395da652eaf32d69bb45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ff6e5fa16f4da33a69814caa2954dc9
publicationDate 2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114209668-A
titleOfInvention A kind of alfuzosin hydrochloride sustained-release preparation and preparation method thereof
abstract The invention belongs to the field of sustained-release preparations, in particular to an alfuzosin hydrochloride sustained-release preparation and a preparation method thereof. The alfuzosin hydrochloride sustained-release preparation provided by the present invention comprises drug-carrying pellets, a sustained-release coating layer, and a pharmaceutical excipient layer, wherein the drug-carrying pellets comprise alfuzosin hydrochloride, filler, plasticizer, Sustained-release matrix material, lubricant, stabilizer; sustained-release coating layer includes film-forming material, plasticizer, lubricant, and purified water. The pharmaceutical excipient layer includes fillers, disintegrants, flavoring agents, lubricants and glidants. Alfuzosin hydrochloride orally disintegrating tablet is characterized in that it can disintegrate or dissolve without water in the oral cavity. It has the characteristics of convenient administration, fast absorption and high bioavailability, which can improve the compliance of patients with medication and increase the clinical application of doctors. The choice of medication for different patients.
priorityDate 2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HK-1020875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101095681-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2820319-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10925912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57501610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454362367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426484532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425321872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411287799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448178750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25137863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385

Total number of triples: 62.